All Stories

  1. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation

    Article • Drug Metabolism Letters, November 2018, Bentham Science Publishers

    Upendra Argikar

  2. The mesentery: an ADME perspective on a ‘new’ organ

    Article • Drug Metabolism Reviews, July 2018, Taylor & Francis

    Upendra Argikar

  3. Investigation of Ocular Bioactivation Potential and the Role of Cytochrome P450 2D Enzymes in Rat

    Article • Drug Metabolism Letters, February 2018, Bentham Science Publishers

    Upendra Argikar

  4. Genotoxicity of 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido[2,3-e][1,2,4] triazolo[4,3-a]pyrazine, a Potent H4 Receptor Antagonist for the Treatment of Allergy: Evidence of Glyoxal Intermediate Involvement

    Article • Drug Metabolism Letters, February 2018, Bentham Science Publishers

    Upendra Argikar

  5. Saccharolactone: the History, the Myth, and the Practice

    Article • Current Drug Metabolism, December 2017, Bentham Science Publishers

    Upendra Argikar

  6. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes

    Article • Drug Metabolism Reviews, May 2017, Taylor & Francis

    Upendra Argikar

  7. Mass spectrometric responses of drugs and metabolites

    Article • Drug Metabolism and Disposition, March 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Upendra Argikar

  8. Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways

    Article • Drug Metabolism and Disposition, May 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Upendra Argikar